Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |
The second-generation antidepressants are a class of antidepressants characterized primarily by the era of their introduction (approximately coinciding with the 1970s and 1980s), rather than by their chemical structure or by their pharmacological effect. As a consequence, there is some controversy over which treatments actually belong in this class.
The term "Third generation antidepressant" is sometimes used to refer to even newer antidepressants, often selective serotonin reuptake inhibitors such as; fluoxetine, paroxetine and sertraline, as well as some 'Non SSRI' antidepressants such as mirtazapine, nefazodone, venlafaxine, duloxetine and reboxetine. However, this usage is not universal.
This list is not exhaustive, and different sources vary upon which items should be considered second-generation.
- ↑ Olver JS, Burrows GD, Norman TR (2001). Third-generation antidepressants: do they offer advantages over the SSRIs?. CNS Drugs 15 (12): 941–54.
- MeSH Second-Generation+Antidepressive+Agents
- Diagrams at toxlab.co.uk
- Overview at sagepub.com
- Overview at psyweb.com
- Overview at sciencedaily.com
- Overview at sabryabdelfattah.tripod.com
- [katzung basic and clinical pharmacology - antidepressants
|This page uses Creative Commons Licensed content from Wikipedia (view authors).|